2016
DOI: 10.1016/j.clnesp.2016.04.001
View full text
|
|
Share
Samantha J. Cushen, Derek G. Power, Kevin P. Murphy, Ray McDermott, Brendan T. Griffin, Marvin Lim, Louise Daly, Peter MacEneaney, Kathleen O' Sullivan, Carla M. Prado, Aoife M. Ryan

Abstract: Sarcopenia and low MA are associated with neutropenia (grade I-II). Furthermore, presence of anaemia, high volume of visceral fat and BMI <25 kg/m are associated with reduced survival in patients with castrate resistant prostate cancer being treated with docetaxel chemotherapy.